Danny's inspiring survival story
30 May 2020
Danny Strosberg started to feel something was wrong when he noticed constant dizziness, daily headaches, and started to lose his vocabulary.
That’s when a CT scan revealed an egg-sized melanoma in his brain.
Danny underwent surgery to remove the tumour followed by six months of treatment. After a number of other tumours appeared throughout his body, he was placed on an immunotherapy clinical trial. It proved to be life saving.
Thanks to generous supporters, melanoma research has come so far. But we still have a long way to go. Our focus remains on achieving zero deaths from melanoma - a goal we believe we can reach in our lifetime.
“I had a complete response within about six months. All of my tumours disappeared.” Danny
Danny proudly calls himself a melanoma survivor. More than ever, he appreciates life, his friends and loved ones. He loves surfing and spending precious time with his wife Lisa and teenage daughter Gabby.
For patients like Danny, whose melanoma has spread to organs like their brain or lungs, clinical trials of new treatments are giving them a second chance at life.
Any life lost to melanoma is one too many. With your support, we will continue our research effort until we achieve our mission of zero deaths from melanoma.
Danny appreciates how immunotherapy treatment saved his life. Now he wants to give other patients the hope to watch their families grow up.
“The advances in melanoma research are being translated to other cancers, and the potential benefits are limitless. I literally owe my life to the work that is being done at MIA.” Danny
We hope Danny’s story inspires you to consider sending a donation.
Your gift could help fund a game-changing new treatment so that – one day very soon – no-one will die from melanoma.
Click below to donate securely via credit card, PayPal or direct deposit. Gifts over $2 are tax-deductible.
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
We value your privacy and want you to be familiar with how we collect, use and disclose your information.
Melanoma Institute Australia has partnered with IBM Research in Australia to help further advance melanoma identification using cognitive technology.
CEO Carole Renouf chats to senior clinicians and researchers as part of our "4 Questions With..." short video series.
MIA's 'Stop the Spread' campaign has been shortlisted in the 2016 Cannes Lions International Festival of Creativity.
MIA's doctors are converging on Chicago this week along with 40,000 delegates from around the globe at the biggest oncology conference in the world.
We are pleased to announce a recent expansion to the dermatology services at Melanoma Institute Australia.
This International Clinical Trials Day we reflect on the importance of clinical trials and the people who dedicate their lives to helping melanoma patients today and in the future.
MIA has launched its first eBook Melanoma Essentials – A Concise Guide, a resource for GPs and other medical, nursing and allied professionals to help them effectively diagnose and manage cases.
Dr Scot Ebbinghaus chats to us about an exciting clinical trial at MIA and where melanoma treatment is headed in the future.
A new melanoma treatment has been listed on the PBS today, giving another option for advanced melanoma patients.
MIA's Pathology Fellow Dr Louise Jackett tells us why she's joined our fellowship program to learn from the best.
MIA doctors and patient have featured in the final episode of ABC’s ground-breaking series Keeping Australia Alive.
Specialist dermatologists at MIA are researching moles during pregnancy and we are looking for study recruits.
New research is re-writing the textbooks on what we know about melanoma by highlighting the effectiveness of radiotherapy as a treatment, reversing a long-held belief that melanoma was resistant to radiotherapy.
However, Australia's burden of melanoma will stay very high over the next 15 years unless we do more. MIA's Professor Graham Mann explains.
Thank you to everyone involved in making Melanoma March 2016 a huge success
Melanoma March 2016 has officially begun with more than 300 people marching in Rockingham and Devonport.